CARM – carisma therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Carisma Therapeutics, Inc. (NASDAQ: CARM) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
Carisma Therapeutics, Inc. (NASDAQ: CARM) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $1.00 price target on the stock, down previously from $10.00.
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its "in-line" rating re-affirmed by analysts at Evercore ISI. They now have a $0.70 price target on the stock, down previously from $4.00.
Carisma Therapeutics, Inc. (NASDAQ: CARM) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.
Form 8-K Carisma Therapeutics For: Dec 07
Form 10-Q Carisma Therapeutics For: Sep 30
Form 8-K Carisma Therapeutics For: Nov 07
Form 4 Carisma Therapeutics For: Oct 31 Filed by: Cheng Sohanya Roshan
Form 3 Carisma Therapeutics For: Oct 31 Filed by: Cheng Sohanya Roshan
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.